Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.91% |
| 2 | Technology | 4.35% |
| 3 | Healthcare | 4.25% |
| 4 | Industrials | 4.06% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
UnitedHealth
UNH
$361B
| $156M | 0.07% |
585,782
+415,488
| +244% | +$108M |
|
252
Synopsys
SNPS
$78.7B
| $155M | 0.07% |
1,575,741
+1,238,780
| +368% | +$118M |
|
253
CALL
Tilray
TLRY
$651M
| $155M | 0.07% |
+108,190
| New | +$69.5M |
|
254
Dollar Tree
DLTR
$24.6B
| $154M | 0.07% |
1,893,845
-206,913
| -10% | -$18.2M |
|
255
Align Technology
ALGN
$12.3B
| $154M | 0.07% |
393,648
+352,328
| +853% | +$130M |
|
256
CALL
Abbott
ABT
$190B
| $154M | 0.07% |
2,098,300
+1,542,000
| +277% | +$101M |
|
257
Thomson Reuters
TRI
$45.4B
| $154M | 0.07% |
2,901,509
+2,793,487
| +2,586% | +$140M |
|
258
Xerox
XRX
$423M
| $153M | 0.07% |
5,671,227
+4,171,362
| +278% | +$110M |
|
|
CELG
259
CALL
DELISTED
Celgene Corp
CELG
| $153M | 0.07% |
1,708,800
-527,800
| -24% | -$46.6M |
|
260
Entergy
ETR
$49.7B
| $152M | 0.07% |
3,757,656
-586,928
| -14% | -$24.3M |
|
261
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $152M | 0.07% |
377,200
+125,300
| +50% | +$47.7M |
|
262
Eversource Energy
ES
$26.8B
| $152M | 0.07% |
2,479,179
+2,270,599
| +1,089% | +$139M |
|
263
CALL
iShares MSCI EAFE ETF
EFA
$79.9B
| $152M | 0.07% |
2,235,200
+407,700
| +22% | +$27.5M |
|
264
Apple
AAPL
$4.45T
| $152M | 0.07% |
2,688,184
+222,392
| +9% | +$11.6M |
|
265
CALL
VanEck Semiconductor ETF
SMH
$70.6B
| $152M | 0.07% |
2,849,000
-591,400
| -17% | -$31.4M |
|
266
Norfolk Southern
NSC
$75.2B
| $150M | 0.07% |
832,407
-480,638
| -37% | -$82.1M |
|
|
EVHC
267
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $149M | 0.07% |
3,262,002
+3,063,920
| +1,547% | +$138M |
|
268
PUT
JD.com
JD
$43.1B
| $148M | 0.07% |
5,654,100
+58,300
| +1% | +$1.91M |
|
269
JPMorgan Chase
JPM
$962B
| $147M | 0.07% |
1,299,418
-769,849
| -37% | -$87.4M |
|
270
PUT
Mastercard
MA
$492B
| $146M | 0.07% |
654,600
-77,300
| -11% | -$16.1M |
|
271
CALL
Johnson & Johnson
JNJ
$626B
| $146M | 0.07% |
1,054,400
+40,900
| +4% | +$5.44M |
|
272
AbbVie
ABBV
$442B
| $146M | 0.06% |
1,539,639
-187,012
| -11% | -$17.7M |
|
273
Bunge Global
BG
$21.4B
| $145M | 0.06% |
2,115,102
+612,723
| +41% | +$40.4M |
|
274
HCA Healthcare
HCA
$89.1B
| $145M | 0.06% |
1,043,787
+1,039,107
| +22,203% | +$129M |
|
|
VXX
275
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $145M | 0.06% |
5,437,700
-1,986,800
| -27% | -$59.7M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.